Clinical trials
Phase 3 trials in Czechia with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 6 |
| Institute for Clinical and Experimental Medicine | 3 |
| University Hospital, Motol | 3 |
| Antisoma Research | 1 |
| Aquinox Pharmaceuticals (Canada) Inc. | 1 |
| Biocad | 1 |
| Boston Scientific Corporation | 1 |
| Charles University, Czech Republic | 1 |
| Czech Lymphoma Study Group | 1 |
| Develco Pharma Schweiz AG | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 8 |
| Coronary Artery Disease | 3 |
| Anemia, Refractory | 2 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Myelodysplastic Syndromes | 2 |
| Atrial Fibrillation | 1 |
| Bites and Stings | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.